AIMS: We tested whether patrons of the night-time economy who had co-consumed energy drinks or illicit stimulants with alcohol had higher blood alcohol concentration (BAC) levels than patrons who had consumed only alcohol. DESIGN: Street intercept surveys (n = 4227) were undertaken between 9 p.m. and 5 a.m. over a period of 7 months. SETTING: Interviews were undertaken with patrons walking through entertainment precincts, queuing to enter venues or exiting venues in five Australian cities. PARTICIPANTS: The response rate was 92.1%; more than half the study sample was male (60.2%) and the median age was 23 years (range 18-72). MEASUREMENTS: Data were collected on demographics, length of drinking session, venue types visited, types and quantity of alcohol consumed and other substance use. A BAC reading was recorded and a subsample of participants was tested for other drug use. FINDINGS: Compared with the total sample (0.068%), illicit stimulant consumers (0.080%; P = 0.004) and energy drink consumers (0.074%; P < 0.001) had a significantly higher median BAC reading, and were more likely to engage in pre-drinking (65.6, 82.1 and 77.6%, respectively, P < 0.001) and longer drinking sessions (4, 5 and 4.5 hours, respectively, P < 0.001). However, stimulant use was not associated independently with higher BAC in the final multivariable model (illicit stimulants P = 0.198; energy drinks P = 0.112). Interaction analyses showed that stimulant users had a higher BAC in the initial stages of the drinking session, but not after 4-6 hours. CONCLUSIONS: While stimulant use does not predict BAC in and of itself, stimulants users are more likely to engage in prolonged sessions of heavy alcohol consumption and a range of risk-taking behaviours on a night out, which may explain higher levels of BAC among stimulants users, at least in the initial stages of the drinking session.
AIMS: We tested whether patrons of the night-time economy who had co-consumed energy drinks or illicit stimulants with alcohol had higher blood alcohol concentration (BAC) levels than patrons who had consumed only alcohol. DESIGN: Street intercept surveys (n = 4227) were undertaken between 9 p.m. and 5 a.m. over a period of 7 months. SETTING: Interviews were undertaken with patrons walking through entertainment precincts, queuing to enter venues or exiting venues in five Australian cities. PARTICIPANTS: The response rate was 92.1%; more than half the study sample was male (60.2%) and the median age was 23 years (range 18-72). MEASUREMENTS: Data were collected on demographics, length of drinking session, venue types visited, types and quantity of alcohol consumed and other substance use. A BAC reading was recorded and a subsample of participants was tested for other drug use. FINDINGS: Compared with the total sample (0.068%), illicit stimulant consumers (0.080%; P = 0.004) and energy drink consumers (0.074%; P < 0.001) had a significantly higher median BAC reading, and were more likely to engage in pre-drinking (65.6, 82.1 and 77.6%, respectively, P < 0.001) and longer drinking sessions (4, 5 and 4.5 hours, respectively, P < 0.001). However, stimulant use was not associated independently with higher BAC in the final multivariable model (illicit stimulants P = 0.198; energy drinks P = 0.112). Interaction analyses showed that stimulant users had a higher BAC in the initial stages of the drinking session, but not after 4-6 hours. CONCLUSIONS: While stimulant use does not predict BAC in and of itself, stimulants users are more likely to engage in prolonged sessions of heavy alcohol consumption and a range of risk-taking behaviours on a night out, which may explain higher levels of BAC among stimulants users, at least in the initial stages of the drinking session.
Authors: Mary M Sweeney; Steven E Meredith; Daniel P Evatt; Roland R Griffiths Journal: Psychopharmacology (Berl) Date: 2017-01-20 Impact factor: 4.530
Authors: Harold L Haun; Anne C K Olsen; Katharina E Koch; Lauryn N Luderman; Christina E May; William C Griffin Journal: Alcohol Date: 2021-03-26 Impact factor: 2.558
Authors: Kerri Coomber; Richelle Mayshak; Shannon Hyder; Nicolas Droste; Ashlee Curtis; Amy Pennay; William Gilmore; Tina Lam; Tanya Chikritzhs; Peter G Miller Journal: Int J Environ Res Public Health Date: 2017-01-12 Impact factor: 3.390
Authors: Joris C Verster; Sarah Benson; Sean J Johnson; Chris Alford; Samuel Benrejeb Godefroy; Andrew Scholey Journal: Hum Psychopharmacol Date: 2018-02-08 Impact factor: 1.672
Authors: Clara Pérez-Mañá; Julián Andrés Mateus; Patricia Díaz-Pellicer; Ariadna Díaz-Baggerman; Marta Pérez; Mitona Pujadas; Francina Fonseca; Esther Papaseit; Jesús Pujol; Klaus Langohr; Rafael de la Torre Journal: Int J Neuropsychopharmacol Date: 2022-01-12 Impact factor: 5.176